Guest - w'd love to know what you think about the forum! Take the 2025 Survey »

FDA Warns of Ketoacidosis Risk With SGLT2 Inhibitors

Thread starter CollieBoy
Start Date May 16, 2015

CollieBoy

Well-Known Member

May 16, 2015

#1

FDA Warns of Ketoacidosis Risk With SGLT2 Inhibitors
From endocrinology advisor:
http://www.endocrinologyadvisor.com...1&spJobID=541022624&spReportId=NTQxMDIyNjI0S0

You must log in or register to reply here.

Share:

Facebook X Bluesky LinkedIn Reddit Pinterest Tumblr WhatsApp Email Link